Sponsor:
University of Alabama at Birmingham
Code:
NCT07523113
Conditions
ME/CFS
ME/CFS Following EBV-associated Infectious Mononucleosis
ME/CFS Following COVID-19
Chronic Fatigue
Chronic Fatigue Syndrome (CFS)
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Processing Speed Training
In-session Instrumental Activities of Daily Living Training
Transfer Package
Follow Up Phone Calls
Trans-auricular Vagus Nerve Stimulation: High Intensity
Brief summary:
Conditions
ME/CFS
ME/CFS Following EBV-associated Infectious Mononucleosis
ME/CFS Following COVID-19
Chronic Fatigue
Chronic Fatigue Syndrome (CFS)
Study ID
NCT07523113
Start date
Jun 23, 2026
Status verified date
Aug, 2026
Completion date
Jun, 2028
Anticipated
Primary completion date
Jun, 2027
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Enrollment
30 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Treatment
Arms
experimental: CICT + taVNS
active comparator: BFT + taVNS
Interventions
Processing Speed Training
In-session Instrumental Activities of Daily Living Training
Transfer Package
Follow Up Phone Calls
Trans-auricular Vagus Nerve Stimulation: High Intensity
In-session Brain Health Training
Reaction Time Training
Trans-auricular Vagus Nerve Stimulation: Low Intensity
Primary outcome measure
Central contacts
Locations
University of Alabama at Birmingham
Recruiting
Birmingham, Alabama, United States, 35294
Contacts
Principal Investigator:
Gitendra Uswatte, PhD
Sponsor
University of Alabama at Birmingham
Last update posted
Aug 14, 2026
Last verified
Aug, 2026
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-10-03. This information was provided to ClinicalTrials.gov by University of Alabama at Birmingham on 2026-08-14. Recruitment status is synced daily from ClinicalTrials.gov and may not reflect the sponsor's current status. Confirm during your call.